Big Molecule Watch
- CuraTeQ Biologics’ Trastuzumab biosimilar Receives Positive Opinion in Europe April 30, 2025 Beth Ashbridge
- Update on Regeneron’s Supplemental BLA for EYLEA HD April 29, 2025 Daniel Farraye
- Regeneron, Mylan, and Biocon Settle in Aflibercept BPCIA Litigation April 28, 2025 Allegra Padula
- Celltrion Adalimumab Biosimilar Granted Interchangeability Designation April 18, 2025 Zachariah Holmes
- FDA to Phase Out Animal Testing for Monoclonal Antibodies and Other Drugs April 15, 2025 Darlene Staines
- FDA Approves Biocon Biologics’ Bevacizumab Biosimilar April 11, 2025 Darlene Staines
- Teva and Samsung Bioepis Announce U.S. Launch of EPYSQLI® (eculizumab-aagh), a SOLIRIS® Biosimilar April 9, 2025 Darlene Staines
- GSK and Pfizer Stipulate to Dismissal of RSV Vaccines Lawsuit April 7, 2025 Timothy Beavers
- EMA Seeks Input on a “Tailored Clinical Approach” in Biosimilar Development April 7, 2025 Timothy Beavers
- Accord Receives Positive EMA Opinion for Two Denosumab Biosimilars April 7, 2025 Timothy Beavers